dr. M. (Margot) Jak

dr. M. (Margot) Jak

Assistant Professor - medical
  • Department of Hematology

Research Programs

Research Output (7)

Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities

de Boer Janneke W, Keijzer Kylie, Pennings Elise R A, van Doesum Jaap A, Spanjaart Anne M, Jak Margot, Mutsaers Pim G N J, van Dorp Suzanne, Vermaat Joost S P, van der Poel Marjolein W M, van Dijk Lisanne V, Kersten Marie José, Niezink Anne G H, van Meerten Tom, 16 Nov 2023, In: Cancers. 15 , p. 1-15

Inflammatory reactions mimic residual or recurrent lymphoma on [<sup>18</sup>F]FDG-PET/CT after CD19-directed CAR T-cell therapy

de Boer Janneke W., Pennings Elise R.A., Kleinjan Ankie, van Doesum Jaap A., Spanjaart Anne M., Mutsaers Pim G.N.J., Jak Margot, van der Poel Marjolein W.M., Kuipers Maria T., Adam Judit A., Diepstra Arjan, Koens Lianne, van Dorp Suzanne, Vermaat Joost S.P., Niezink Anne G.H., Kersten Marie José, van Meerten Tom 14 Nov 2023, In: Blood Advances. 7 , p. 6710-6716 7 p.

The Dutch CAR-T Tumorboard Experience:Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands

Spanjaart Anne M, Pennings Elise R A, Mutsaers Pim G N J, van Dorp Suzanne, Jak Margot, van Doesum Jaap A, de Boer Janneke W, Niezink Anne G H, Kos Milan, Vermaat Joost S P, Sijs-Szabo Aniko, van der Poel Marjolein W M, Nijhof Inger S, Kuipers Maria T, Chamuleau Martine E D, Lugtenburg Pieternella J, Doorduijn Jeanette K, Serroukh Yasmina I M, Minnema Monique C, van Meerten Tom, Kersten Marie José, 30 Aug 2023, In: Cancers. 15

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities

Spanjaart Anne M, Pennings Elise R A, Kos Milan, Mutsaers Pim G N J, Lugtenburg Pieternella J, van Meerten Tom, van Doesum Jaap A, Minnema Monique C, Jak Margot, van Dorp Suzanne, Vermaat Joost S P, van der Poel Marjolein W M, van Oijen Martijn G H, Kuipers Maria T, Nijhof Inger S, Kersten Marie José 12 Dec 2022, In: JCO oncology practice. 19 , p. e407-e416 10 p.

Differences and Similarities in Treatment Paradigms and Goals between AL Amyloidosis and Multiple Myeloma

Minnema Monique C., Oostvogels Rimke, Raymakers Reinier, Jak Margot Dec 2021, In: Hemato. 2 , p. 680-691 12 p.

CD38 and CD45 expression on plasma cells and response to daratumumab in Multiple Myeloma

Lammers Eline, Cuenca Marta, Bloem Andries, Minnema Monique, Jak Margot Oct 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E164-E164

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients

Oostvogels Rimke, Jak Margot, Raymakers Reinier, Mous Rogier, Minnema Monique C. 1 Oct 2018, In: British Journal of Haematology. 183 , p. 60-67 8 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not